Analysts launch coverage of Accelevation with overweight and equal‑weight ratings and $18‑$20 price targets
JPMorgan, Barclays and BofA each initiated coverage of Accelevation Holdings with overweight or buy ratings and a $20 price target, while Morgan Stanley started coverage with an equal‑weight rating and an $18 target. The analysts highlighted the company’s exposure to AI‑driven datacenter growth and cited strong revenue visibility. Accelevation currently trades around $12.38, near its 52‑week low.
Why it matters
The new coverage and price targets suggest potential upside of roughly 20‑60% for investors, depending on the analyst, and may drive trading interest in ACCV. BofA’s forecast of a 56% CAGR in adjusted EBITDA through 2030 signals strong growth expectations that could affect valuation models.
Key facts
- 1JPMorgan initiated coverage with an overweight rating and a $20.00 price target. investing.com
- 2Barclays initiated coverage with an overweight rating and a $20.00 price target. investing.com
- 3Barclays projects 71% sales growth and 72% EBITDA growth CAGR from FY2025 through FY2028. investing.com
- 4Morgan Stanley initiated coverage with an equal‑weight rating and an $18.00 price target. investing.com
- 5BofA Securities initiated coverage with a buy rating and a $20.00 price target. investing.com
- 6BofA forecasts adjusted EBITDA to increase at a 56% CAGR from 2026 through 2030. investing.com
Summary written by AlphAI AI Desk from 6 of 6 sources. Not investment advice. Figures are as stated by the linked sources.